Artwork

Contenu fourni par Dr Luc Lanthier et collaborateurs and Dr Luc Lanthier. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr Luc Lanthier et collaborateurs and Dr Luc Lanthier ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

BC 038 – Finérénone chez les sujets avec diabète type 2, albuminurie et insuffisance rénale chronique (étude FIDELIO-DKD)

37:25
 
Partager
 

Série archivée ("Flux inactif" status)

When? This feed was archived on August 20, 2023 01:52 (8M ago). Last successful fetch was on June 27, 2023 03:37 (10M ago)

Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 308806286 series 3020671
Contenu fourni par Dr Luc Lanthier et collaborateurs and Dr Luc Lanthier. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr Luc Lanthier et collaborateurs and Dr Luc Lanthier ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Dans cette 38e baladodiffusion, le Dr Luc Lanthier discute de l’efficacité de la finérénone dans le traitement des sujets avec diabète type 2, albuminurie et insuffisance rénale chronique, en plus de réviser la littérature médicale d’octobre et novembre 2020.

Quiz clinique (4min21), étude principale (4min44), critique (24min31), autres articles (29min32), réponse au quiz clinique (34min33)

Référence principale

Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020;383(23):2219-29. PubMed PMID: 33264825.

Articles associés

Ingelfinger JR, Rosen CJ. Finerenone – Halting Relative Hyperaldosteronism in Chronic Kidney Disease. N Engl J Med. 2020;383(23):2285-2286. PubMed PMID: 33095527.

Filippatos G, Anker SD, Agarwal R, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Schloemer P, Tornus I, Joseph A, Bakris GL; FIDELIO-DKD Investigators. Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes. Circulation. 2020 Nov 16. doi: 10.1161/CIRCULATIONAHA.120.051898. PubMed PMID: 33198491.

Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Pitt B; FIGARO-DKD study investigators. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial. Am J Nephrol. 2019;50(5):345-356. PubMed PMID: 31665733.

Horwitz LI, Jones SA, Cerfolio RJ, Francois F, Greco J, Rudy B, et al. Trends in COVID-19 Risk-Adjusted Mortality Rates. J Hosp Med. 2020. PubMed PMID: 33147129.

Group RC, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, et al. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020;383(21):2030-40. PubMed PMID: 33031652.

Horby PW, Mafham M, Bell JL, Linsell L, Staplin N, Emberson J, et al. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020;396(10259):1345-52. PubMed PMID: 33031764.

Consortium WHOST, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, et al. Repurposed Antiviral Drugs for Covid-19 – Interim WHO Solidarity Trial Results. N Engl J Med. 2020. PubMed PMID: 33264556.

Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, et al. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020;383(24):2333-44. PubMed PMID: 33085857.

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577. PubMed PMID: 33301246.

Rubin EJ, Longo DL. SARS-CoV-2 Vaccination – An Ounce (Actually, Much Less) of Prevention. N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717. Epub ahead of print. PubMed PMID: 33301245.

Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, et al. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J. 2020;41(42):4092-9. PubMed PMID: 32860034.

Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Gregoire JC, et al. Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes. 2020. PubMed PMID: 32407460.

Roubille F, Tardif JC. Colchicine for Secondary Cardiovascular Prevention in Coronary Disease. Circulation. 2020;142(20):1901-4. PubMed PMID: 33196312.

Samuel M, Waters DD. Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention? Can J Cardiol. 2020;36(11):1697-9. PubMed PMID: 32585327.

Lopes RD, Alexander KP, Stevens SR, Reynolds HR, Stone GW, Pina IL, et al. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial. Circulation. 2020;142(18):1725-35. PubMed PMID: 32862662.

Li N, Zhao G, Wu W, Zhang M, Liu W, Chen Q, et al. The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(11):e2023644. PubMed PMID: 33136134.

Autres articles d’intérêt

Octobre

Carlsson LMS, Sjoholm K, Jacobson P, Andersson-Assarsson JC, Svensson PA, Taube M, et al. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study. N Engl J Med. 2020;383(16):1535-43. PubMed PMID: 33053284.

Richards T, Baikady RR, Clevenger B, Butcher A, Abeysiri S, Chau M, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet. 2020;396(10259):1353-61. PubMed PMID: 32896294.

Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, Eshima K, Tanizawa K, Fukuzawa M, Hayashi T, Akishita M, Lip GYH, Yamashita T; ELDERCARE-AF Committees and Investigators. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. N Engl J Med. 2020;383(18):1735-1745. PubMed PMID: 32865374.

Novembre

Lamb SE, Bruce J, Hossain A, Ji C, Longo R, Lall R, et al. Screening and Intervention to Prevent Falls and Fractures in Older People. N Engl J Med. 2020;383(19):1848-59. PubMed PMID: 33211928.

Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020;396(10263):1637-43. PubMed PMID: 33186535.

Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644-52. PubMed PMID: 33186534.

Guimaraes HP, Lopes RD, de Barros ESPGM, Liporace IL, Sampaio RO, Tarasoutchi F, et al. Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. N Engl J Med. 2020;383(22):2117-26. PubMed PMID: 33196155.

Guides de pratique

Diabetes Canada Clinical Practice Guidelines Expert C, Lipscombe L, Butalia S, Dasgupta K, Eurich DT, MacCallum L, et al. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update. Can J Diabetes. 2020;44(7):575-91. PubMed PMID: 32972640.

Diabetes Canada Clinical Practice Guidelines Steering C, Senior PA, Houlden RL, Kim J, Mackay D, Nagpal S, et al. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update – The User’s Guide. Can J Diabetes. 2020;44(7):592-6. PubMed PMID: 32972641.

de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, et al. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020;98(4):839-48. PubMed PMID: 32653403.

Kidney Disease: Improving Global Outcomes Diabetes Work G. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4S):S1-S115. PubMed PMID: 32998798

Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-738. PubMed PMID: 33007077.

Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651-69. PubMed PMID: 33052386.

Jacobs SS, Krishnan JA, Lederer DJ, Ghazipura M, Hossain T, Tan AM, et al. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(10):e121-e41. PubMed PMID: 33185464.

Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, et al. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. CMAJ. 2020;192(46):E1453-E68. PubMed PMID: 33199452.

Référence du quiz clinique

The Curious Clinicians – A Medical Podcast that asks « Why »?

Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol. 2004 Jun;203(2):721-8. PubMed PMID: 15141388.

  continue reading

50 episodes

Artwork
iconPartager
 

Série archivée ("Flux inactif" status)

When? This feed was archived on August 20, 2023 01:52 (8M ago). Last successful fetch was on June 27, 2023 03:37 (10M ago)

Why? Flux inactif status. Nos serveurs ont été incapables de récupérer un flux de podcast valide pour une période prolongée.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 308806286 series 3020671
Contenu fourni par Dr Luc Lanthier et collaborateurs and Dr Luc Lanthier. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr Luc Lanthier et collaborateurs and Dr Luc Lanthier ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Dans cette 38e baladodiffusion, le Dr Luc Lanthier discute de l’efficacité de la finérénone dans le traitement des sujets avec diabète type 2, albuminurie et insuffisance rénale chronique, en plus de réviser la littérature médicale d’octobre et novembre 2020.

Quiz clinique (4min21), étude principale (4min44), critique (24min31), autres articles (29min32), réponse au quiz clinique (34min33)

Référence principale

Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020;383(23):2219-29. PubMed PMID: 33264825.

Articles associés

Ingelfinger JR, Rosen CJ. Finerenone – Halting Relative Hyperaldosteronism in Chronic Kidney Disease. N Engl J Med. 2020;383(23):2285-2286. PubMed PMID: 33095527.

Filippatos G, Anker SD, Agarwal R, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Schloemer P, Tornus I, Joseph A, Bakris GL; FIDELIO-DKD Investigators. Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes. Circulation. 2020 Nov 16. doi: 10.1161/CIRCULATIONAHA.120.051898. PubMed PMID: 33198491.

Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Pitt B; FIGARO-DKD study investigators. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial. Am J Nephrol. 2019;50(5):345-356. PubMed PMID: 31665733.

Horwitz LI, Jones SA, Cerfolio RJ, Francois F, Greco J, Rudy B, et al. Trends in COVID-19 Risk-Adjusted Mortality Rates. J Hosp Med. 2020. PubMed PMID: 33147129.

Group RC, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, et al. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020;383(21):2030-40. PubMed PMID: 33031652.

Horby PW, Mafham M, Bell JL, Linsell L, Staplin N, Emberson J, et al. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020;396(10259):1345-52. PubMed PMID: 33031764.

Consortium WHOST, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, et al. Repurposed Antiviral Drugs for Covid-19 – Interim WHO Solidarity Trial Results. N Engl J Med. 2020. PubMed PMID: 33264556.

Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, et al. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020;383(24):2333-44. PubMed PMID: 33085857.

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577. PubMed PMID: 33301246.

Rubin EJ, Longo DL. SARS-CoV-2 Vaccination – An Ounce (Actually, Much Less) of Prevention. N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717. Epub ahead of print. PubMed PMID: 33301245.

Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, et al. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J. 2020;41(42):4092-9. PubMed PMID: 32860034.

Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Gregoire JC, et al. Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes. 2020. PubMed PMID: 32407460.

Roubille F, Tardif JC. Colchicine for Secondary Cardiovascular Prevention in Coronary Disease. Circulation. 2020;142(20):1901-4. PubMed PMID: 33196312.

Samuel M, Waters DD. Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention? Can J Cardiol. 2020;36(11):1697-9. PubMed PMID: 32585327.

Lopes RD, Alexander KP, Stevens SR, Reynolds HR, Stone GW, Pina IL, et al. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial. Circulation. 2020;142(18):1725-35. PubMed PMID: 32862662.

Li N, Zhao G, Wu W, Zhang M, Liu W, Chen Q, et al. The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(11):e2023644. PubMed PMID: 33136134.

Autres articles d’intérêt

Octobre

Carlsson LMS, Sjoholm K, Jacobson P, Andersson-Assarsson JC, Svensson PA, Taube M, et al. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study. N Engl J Med. 2020;383(16):1535-43. PubMed PMID: 33053284.

Richards T, Baikady RR, Clevenger B, Butcher A, Abeysiri S, Chau M, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet. 2020;396(10259):1353-61. PubMed PMID: 32896294.

Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, Eshima K, Tanizawa K, Fukuzawa M, Hayashi T, Akishita M, Lip GYH, Yamashita T; ELDERCARE-AF Committees and Investigators. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. N Engl J Med. 2020;383(18):1735-1745. PubMed PMID: 32865374.

Novembre

Lamb SE, Bruce J, Hossain A, Ji C, Longo R, Lall R, et al. Screening and Intervention to Prevent Falls and Fractures in Older People. N Engl J Med. 2020;383(19):1848-59. PubMed PMID: 33211928.

Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020;396(10263):1637-43. PubMed PMID: 33186535.

Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644-52. PubMed PMID: 33186534.

Guimaraes HP, Lopes RD, de Barros ESPGM, Liporace IL, Sampaio RO, Tarasoutchi F, et al. Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. N Engl J Med. 2020;383(22):2117-26. PubMed PMID: 33196155.

Guides de pratique

Diabetes Canada Clinical Practice Guidelines Expert C, Lipscombe L, Butalia S, Dasgupta K, Eurich DT, MacCallum L, et al. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update. Can J Diabetes. 2020;44(7):575-91. PubMed PMID: 32972640.

Diabetes Canada Clinical Practice Guidelines Steering C, Senior PA, Houlden RL, Kim J, Mackay D, Nagpal S, et al. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update – The User’s Guide. Can J Diabetes. 2020;44(7):592-6. PubMed PMID: 32972641.

de Boer IH, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, et al. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020;98(4):839-48. PubMed PMID: 32653403.

Kidney Disease: Improving Global Outcomes Diabetes Work G. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4S):S1-S115. PubMed PMID: 32998798

Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-738. PubMed PMID: 33007077.

Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651-69. PubMed PMID: 33052386.

Jacobs SS, Krishnan JA, Lederer DJ, Ghazipura M, Hossain T, Tan AM, et al. Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(10):e121-e41. PubMed PMID: 33185464.

Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, et al. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. CMAJ. 2020;192(46):E1453-E68. PubMed PMID: 33199452.

Référence du quiz clinique

The Curious Clinicians – A Medical Podcast that asks « Why »?

Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol. 2004 Jun;203(2):721-8. PubMed PMID: 15141388.

  continue reading

50 episodes

Tous les épisodes

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide